InvestorsHub Logo
icon url

tompinva

01/19/16 4:38 PM

#553 RE: Deuces #551

Partnership including AVDX & ARYC, could propel to $1 pps. Buyout rumors with strong company, we'd be looking closer to that $2, ARYC says is their BO price.
icon url

rainbow898

01/20/16 5:54 AM

#557 RE: Deuces #551

Yeap, good partnership for AVDX.

Concurrent with this announcement, Amarantus Diagnostics has entered into an agreement with a Maryland-based CLIA laboratory to house its assays in preparation for CLIA-enabling validation studies. Upon closing of the merger transaction, Avant Diagnostics will take over this agreement and be positioned to complete the development of OvaDx in that CLIA-certified facility.



http://finance.yahoo.com/news/amarantus-enters-letter-intent-merge-140000225.html


icon url

rainbow898

01/20/16 6:37 AM

#558 RE: Deuces #551

Interesting interview with Amarantus CEO.
He talked about merging with other diagnostic company that has complimentary technology like AVDX that will become spin-out strategy as a separate entity(after 8.00 min).